In all, 62.0% (268/432), 84.6% (365) and 98.83% (427/432) of the respondents were adherent to medications, lifestyle/behavioural treatments and review attendance respectively. High HRQoL (aOR=2.07, 95% CI: 1.15 – 3.73) and low PSS (aOR= 2.29 (1.33 – 3.95) were associated with increased odds of adherence to lifestyle/behavourial treatments. Only High HRQoL was found to be crudely associated with medications cOR= 1.49 (1.01 – 2.21), though this result could not be included in a multiregression model. No predictor variable was found to be associated with review attendance.